peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Event

Investor relations contact

Investor Relations

Klaus Sindahl

Head of Investor Relations

Mobile: +46 (0) 709 298 269

Email: klaus.sindahl@hansabiopharma.com